Drug monitoring of a case of citalopram overdosage

Drug Chem Toxicol. 2011 Oct;34(4):420-3. doi: 10.3109/01480545.2011.566571. Epub 2011 Aug 16.

Abstract

Selective serotonin reuptake inhibitors are widely prescribed drugs without recognized cardiovascular risk. We report the case of a 54-year-old patient who developed QTc interval prolongation, followed by ventricular fibrillation episodes, 10 hours after admission to the ICU, in the setting of a citalopram overdose. Citalopram plasma values dropped from 5.88 to 0.34 mg/L at 9 days postadmission. The patient was treated by oral activated charcoal, and final outcome was favorable.

Publication types

  • Case Reports

MeSH terms

  • Citalopram / administration & dosage
  • Citalopram / adverse effects*
  • Citalopram / blood*
  • Citalopram / therapeutic use
  • Drug Monitoring*
  • Drug Overdose
  • Electrocardiography
  • Female
  • Half-Life
  • Humans
  • Long QT Syndrome / blood
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / drug therapy
  • Middle Aged
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / blood*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Treatment Outcome
  • Ventricular Fibrillation / blood
  • Ventricular Fibrillation / chemically induced
  • Ventricular Fibrillation / drug therapy

Substances

  • Serotonin Uptake Inhibitors
  • Citalopram